PERSPECTIVE

  • Trend

    Should you buy DMart at its current market price of ₹2,190?

    The retail stock has jumped almost 50% from its 52-week low, but with Jio entering the space, its valuation may be at risk

    August 17, 2020
  • Trend

    Astec LifeSciences MD Ashok Hiremath sells stock worth ₹165 million

    The stock has rallied on the back of strong earnings growth and overall optimism for pharma sector 

    Shailaja Mohapatra - August 13, 2020
  • Feature

    Can agri-input companies continue to stay investor darlings?

    Good rains and a pandemic pandemonium have made this sector appealing 

    Anishaa Kumar - August 12, 2020
  • Feature

    Is KEI on the cusp of transformation?

    The cable manufacturer may need to get into a competitive space to change its fortunes 

    Debangana Ghosh - July 31, 2020
  • Trend

    Laughing all the way, but not to the bank

    Months ahead of his last day at office, HDFC Bank CEO Aditya Puri offloads shares worth Rs.8.43 billion

    Shailaja Mohapatra - July 31, 2020
  • Trend

    Will private sector bank valuations correct further?

    With uncertainty over the magnitude of bad loans due to the moratorium, banks may face a rude shock in the coming months 

    July 31, 2020
  • Feature

    Its IPO was overhyped but is it time to relook at SBI Cards?

    Listing amidst a pandemic hurt its market cap, but analysts feel the SBI subsidiary could bounce back in FY22  

    Anishaa Kumar - July 17, 2020
  • Trend

    Will we see further earnings downgrade post Q1FY21 results?

    As the lockdown continues in several parts of the country, growth is barely picking up 

    July 17, 2020
  • Feature

    Why Ashish Kacholia, Mukul Agrawal and Kedaara Capital are hot on Religare Enterprises

    Despite its troubled past, its healthcare insurance business may turn out to be a dark horse 

    Anishaa Kumar - July 17, 2020
  • Trend

    Info Edge promoters offload part stake post muted Q4

    Sanjeev Bikhchandani and Hitesh Oberoi sell shares worth Rs.226 million 

    Shailaja Mohapatra - July 17, 2020
  • Trend

    Is there more upside in store for pharma stocks?

    Over the past year, the Nifty Pharma Index has gained 23% while the Nifty has declined by 11% 

    July 04, 2020
  • Feature

    Will Shemaroo’s valiant attempt at beating the odds culminate in a happy ending?

    It is a turbulent environment but the content owner-aggregator-distributor is venturing into new territory, leaving investors nervous 

    Shruti Venkatesh - July 04, 2020